WaferGen Q4 Revenues Rise 55 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – WaferGen Biosystems reported after the close of the market on Thursday a 55 percent jump in its fourth quarter revenues.

For the three months ended Dec. 31, 2013, total revenues reached $490,465, up from $316,177 in the prior-year fourth quarter. Product revenues increased to $365,465, compared to $316,177 a year ago, while license and royalty revenues in Q4 2013 were $125,000, compared to zero a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.